Cancer Biobanks and International Collaboration in the European Research Area

Abstract

Biobanks have become critical infrastructures for cancer research, supporting prevention, early detection, therapy development, and follow-up studies. Over the past three decades, cancer biobanks in Europe have expanded from local sample collections to a coordinated network profoundly embedded in international research activities and initiatives. This narrative review is based on a targeted literature and document search in PubMed, Scopus, and Web of Science, as well as European Commission portals and infrastructure websites (1995–2025). Keywords included cancer biobank, BBMRI-ERIC, Horizon Europe, governance, GDPR, interoperability. Sources were screened for relevance to European cancer biobanking initiatives, infrastructures, and governance frameworks. The analysis highlights the role of major European initiatives (FP5–FP9, Horizon Europe, Cancer Mission, Europe’s Beating Cancer Plan) and infrastructures (Biobanking and BioMolecular Resources Research Infrastructure—European Research Infrastructure Consortium [BBMRI-ERIC], canSERV, UNCAN.eu) in shaping cancer biobanking. Achievements include the establishment of large transnational cohorts, the provision of more than 400 oncology services, and growing interoperability standards. Persistent challenges relate to data protection (General Data Protection Regulation), consent management, interoperability (Minimum Information About Biobank Data Sharing and Findable, Accessible, Interoperable, Reusable principles), sustainability, and translation into clinical practice. Cancer biobanks are irreplaceable entities of European cancer research. Their future lies in strengthening governance, ensuring long-term sustainability, enhancing interoperability, and engaging patients and stakeholders. Cancer biobanks contribute to fostering innovation and defining future research. BBMRI-ERIC remains the pivotal gateway, enabling individual biobanks to integrate into large-scale European and international research efforts.

Keywords

cancer biobank BBMRI-ERIC Horizon Europe canSERV governance data interoperability MIABIS

Get full access to this article

View all access options for this article.

References

European Commission. Europe’s Beating Cancer Plan. Communication COM (2021) 44 final. Publications Office of the European Union: Luxembourg; 2021. https://health.ec.europa.eu/system/files/2022-02/eu_cancer-plan_en_0.pdf [December 3, 2025].

Ferlay

, Laversanne

, Ervik

, et al. Global Cancer Observatory: Cancer Tomorrow (version 1.1). International Agency for Research on Cancer: Lyon (FR); 2024. Available from: https://gco.iarc.who.int/tomorrow [Last accessed: December 3, 2025].

OECD, European Commission. EU Country Cancer Profiles Synthesis Report 2025. OECD Publishing: Paris; 2025. doi:10.1787/20ef03e1-en

Shaukat

, Levin

. Current and future colorectal cancer screening strategies. Nat Rev Gastroenterol Hepatol, 2022; 19(8):521–531; doi: 10.1038/s41575-022-00612-y

European Commission. EU Mission: Cancer. Publications Office of the European Union: Luxembourg; 2025. doi:10.2777/2915202

BBMRI-ERIC. Position Paper on the Next EU Framework Programme (FP10, 2028–2034). Graz: BBMRI-ERIC; 2023. https://www.bbmri-eric.eu [December 3, 2025].

European Commission. canSERV Project. Horizon Europe; 2023. Available from: https://cordis.europa.eu/project/id/101058620 [Last accessed: December 3, 2025].

European Commission. Fifth Framework Programme (FP5) for Research, Technological Development and Demonstration (1998–2002). Brussels: European Commission; 1998. Available from: https://cordis.europa.eu/programme/id/FP5 [Last accessed: December 3, 2025].

European Commission. Sixth Framework Programme (FP6) for Research, Technological Development and Demonstration (2002–2006). Brussels: European Commission; 2002. Available from: https://cordis.europa.eu/programme/id/FP6 [Last accessed: December 3, 2025].

10.

European Commission. Seventh Framework Programme (FP7): Specific Programme Capacities—Research Infrastructures. Brussels: European Commission; 2007. Available from: https://cordis.europa.eu/programme/id/FP7 [Last accessed: December 3, 2025].

11.

European Commission. Horizon 2020 Framework Programme for Research and Innovation. Brussels: European Commission; 2014. Available from: https://cordis.europa.eu/programme/id/H2020 [Last accessed: December 3, 2025].

12.

European Commission. Horizon Europe Strategic Plan 2021–2024. Publications Office of the European Union: Luxembourg; 2021; doi:10.2777/083753

13.

ESFRI. Roadmap 2021: Strategy Report on Research Infrastructures. Milan: University of Milan; 2021.

14.

BBMRI-ERIC. ADOPT BBMRI-ERIC Project: Implementation and Operation of the Gateway for Health into BBMRI-ERIC. Graz: BBMRI-ERIC; 2019. Available from: https://www.bbmri-eric.eu [Last accessed: December 3, 2025].

15.

canSERV Consortium. canSERV Project. Horizon Europe; 2022. Available from: https://www.canserv.eu [Last accessed: December 3, 2025].

16.

UNCAN.eu Consortium. European Initiative to UNderstand CANcer (UNCAN.eu). Brussels: European Commission; 2022. Available from: https://www.uncan.eu [Last accessed: December 3, 2025].

17.

Dove

, Townend

, Meslin

, et al. Ethics review for international data-intensive research. Science, 2016; 351(6280):1399–1400; doi: 10.1126/science.aad5269

18.

Mascalzoni

, Dove

, Rubinstein

, et al. International charter of principles for sharing bio-specimens and data. Eur J Hum Genet, 2015; 23(6):721–728; doi: 10.1038/ejhg.2014.197

19.

Maloy

, Bass

PF.

3rd ., Understanding broad consent. Ochsner J, 2020; 20(1):81–86; doi: 10.31486/toj.19.0088

20.

Prictor

, Lewis

, Newson

, et al. Dynamic consent: An evaluation and reporting framework. J Empir Res Hum Res Ethics, 2020; 15(3):175–186; doi: 10.1177/1556264619887073

21.

Tamuhla

, Tiffin

, Allie

. An e-consent framework for tiered informed consent for human genomic research in the global south, implemented as a REDCap template. BMC Med Ethics, 2022; 23(1):119; doi: 10.1186/s12910-022-00860-2

22.

Eklund

, Engels

, Neumann

, et al. Update of the Minimum Information About Biobank Data Sharing (MIABIS) core terminology to the 3rd version. Biopreserv Biobank, 2024; 22(4):346–362; doi: 10.1089/bio.2023.0074

23.

Wilkinson

, Dumontier

, Aalbersberg

, et al. The FAIR guiding principles for scientific data management and stewardship. Sci Data, 2016; 3:160018; doi: 10.1038/sdata.2016.18

24.

European Union. Regulation (EU) 2016/679 of the European Parliament and of the Council of 27 April 2016 (General Data Protection Regulation). Off J Eur Union, 2016; L119:1–88.

25.

BBMRI-ERIC. Policy for Access to and Sharing of Biological Samples and Data. Graz: BBMRI-ERIC; 2020. Available from: https://www.bbmri-eric.eu/services/access-policy [Last accessed: December 3, 2025].

26.

Campbell

, Astrin

, DeSouza

, et al. The 2018 revision of the ISBER best practices. Biopreserv Biobank, 2018; 16(1):3–6; doi: 10.1089/bio.2017.0001

27.

Vaught

, Rogers

, Carolin

, Compton

. Biobankonomics: Developing a sustainable business model approach for the formation of a human tissue biobank. J Natl Cancer Inst Monogr, 2011(;2011(42):24–31; doi: 10.1093/jncimonographs/lgr009

28.

Merino-Martinez

, Norlin

, van Enckevort

, et al. Toward global biobank integration by implementation of the Minimum Information About Biobank Data Sharing (MIABIS 2.0 Core). Biopreserv Biobank, 2016; 14(4):298–306; doi: 10.1089/bio.2015.0070

29.

Goisauf

, Martin

, Bentzen

, et al. Data in question: A survey of European biobank professionals on ELSI challenges. PLoS One, 2019; 14(9):e0221496; doi: 10.1371/journal.pone.0221496

30.

Kohane

, Aronow

, Avillach

, et al.; Consortium For Clinical Characterization Of COVID-19 By EHR (4CE). What every biologist should know about studies using electronic health record data but may be afraid to ask. J Med Internet Res, 2021; 23(3):e22219; doi: 10.2196/22219

31.

Reihs

, Proynova

, Maqsood

, et al. BBMRI-ERIC negotiator: Implementing efficient access to biobanks. Biopreserv Biobank, 2021; 19(5):414–421; doi: 10.1089/bio.2020.0144